Erica Wymore
Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Marijuana Use | 7 | 2023 | 167 | 2.330 |
Why?
| Neonatal Abstinence Syndrome | 2 | 2020 | 13 | 1.370 |
Why?
| Dronabinol | 4 | 2021 | 118 | 0.910 |
Why?
| Milk, Human | 2 | 2021 | 127 | 0.860 |
Why?
| Retinopathy of Prematurity | 6 | 2020 | 111 | 0.850 |
Why?
| Cannabis | 3 | 2023 | 384 | 0.760 |
Why?
| Opiate Alkaloids | 1 | 2020 | 5 | 0.720 |
Why?
| Intensive Care Units, Neonatal | 4 | 2021 | 176 | 0.670 |
Why?
| Infant, Small for Gestational Age | 2 | 2019 | 76 | 0.670 |
Why?
| Bronchopulmonary Dysplasia | 5 | 2021 | 329 | 0.630 |
Why?
| Infant, Newborn | 19 | 2023 | 5043 | 0.620 |
Why?
| Infant, Premature | 7 | 2021 | 476 | 0.600 |
Why?
| Marijuana Abuse | 1 | 2019 | 212 | 0.570 |
Why?
| Substance-Related Disorders | 1 | 2023 | 947 | 0.500 |
Why?
| Opioid-Related Disorders | 1 | 2019 | 413 | 0.420 |
Why?
| Colorado | 9 | 2021 | 4099 | 0.400 |
Why?
| Pregnancy Complications | 3 | 2019 | 429 | 0.360 |
Why?
| Hospitals | 3 | 2023 | 581 | 0.320 |
Why?
| Birth Weight | 4 | 2020 | 440 | 0.310 |
Why?
| Infant, Low Birth Weight | 2 | 2019 | 125 | 0.300 |
Why?
| Infant | 9 | 2023 | 7959 | 0.280 |
Why?
| Gestational Age | 8 | 2021 | 759 | 0.260 |
Why?
| Pregnancy | 7 | 2023 | 5517 | 0.260 |
Why?
| Marijuana Smoking | 2 | 2019 | 224 | 0.260 |
Why?
| Neonatal Screening | 2 | 2018 | 152 | 0.260 |
Why?
| Mothers | 2 | 2023 | 651 | 0.260 |
Why?
| Hospital Mortality | 2 | 2019 | 776 | 0.240 |
Why?
| Infant, Very Low Birth Weight | 3 | 2019 | 66 | 0.220 |
Why?
| Analgesics, Opioid | 2 | 2020 | 771 | 0.210 |
Why?
| Lactation | 1 | 2023 | 149 | 0.200 |
Why?
| Breast Feeding | 2 | 2023 | 368 | 0.200 |
Why?
| Umbilical Cord | 2 | 2021 | 80 | 0.200 |
Why?
| Humans | 25 | 2023 | 114624 | 0.190 |
Why?
| Metabolism | 1 | 2021 | 35 | 0.190 |
Why?
| Metabolism, Inborn Errors | 1 | 2021 | 39 | 0.180 |
Why?
| Hospitalization | 2 | 2019 | 1749 | 0.180 |
Why?
| Algorithms | 2 | 2018 | 1466 | 0.180 |
Why?
| Reference Standards | 1 | 2020 | 159 | 0.170 |
Why?
| Ventricular Septum | 1 | 2019 | 8 | 0.170 |
Why?
| Prenatal Care | 2 | 2019 | 253 | 0.170 |
Why?
| Cannabinoids | 1 | 2021 | 115 | 0.170 |
Why?
| Massachusetts | 1 | 2019 | 134 | 0.160 |
Why?
| Pregnancy Outcome | 2 | 2019 | 337 | 0.160 |
Why?
| Interrupted Time Series Analysis | 1 | 2019 | 44 | 0.160 |
Why?
| Female | 14 | 2023 | 59466 | 0.160 |
Why?
| Self Report | 2 | 2021 | 696 | 0.160 |
Why?
| Enteral Nutrition | 2 | 2011 | 159 | 0.160 |
Why?
| Legislation, Drug | 1 | 2019 | 78 | 0.160 |
Why?
| Infant, Newborn, Diseases | 1 | 2019 | 104 | 0.150 |
Why?
| Echocardiography, Doppler | 1 | 2018 | 91 | 0.150 |
Why?
| Cross-Sectional Studies | 3 | 2023 | 4405 | 0.150 |
Why?
| Abnormalities, Multiple | 1 | 2019 | 178 | 0.140 |
Why?
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.140 |
Why?
| Data Collection | 1 | 2019 | 620 | 0.140 |
Why?
| Echocardiography | 1 | 2019 | 553 | 0.140 |
Why?
| Hyperammonemia | 1 | 2016 | 15 | 0.140 |
Why?
| Risk-Taking | 1 | 2019 | 333 | 0.130 |
Why?
| Weight Gain | 1 | 2019 | 453 | 0.130 |
Why?
| Medical Marijuana | 1 | 2018 | 97 | 0.130 |
Why?
| Portal Vein | 1 | 2016 | 76 | 0.130 |
Why?
| Incidence | 2 | 2019 | 2311 | 0.130 |
Why?
| Vascular Malformations | 1 | 2016 | 47 | 0.130 |
Why?
| Length of Stay | 1 | 2020 | 962 | 0.130 |
Why?
| Adolescent | 4 | 2021 | 17831 | 0.120 |
Why?
| Databases, Factual | 1 | 2019 | 1124 | 0.120 |
Why?
| Insulin-Like Growth Factor I | 1 | 2017 | 286 | 0.120 |
Why?
| Medical Errors | 1 | 2016 | 85 | 0.120 |
Why?
| Heart Defects, Congenital | 2 | 2011 | 671 | 0.110 |
Why?
| Surgical Procedures, Operative | 1 | 2016 | 207 | 0.110 |
Why?
| Prospective Studies | 2 | 2021 | 6217 | 0.110 |
Why?
| Blood Pressure | 1 | 2019 | 1538 | 0.110 |
Why?
| Quality Improvement | 1 | 2020 | 950 | 0.100 |
Why?
| Patient Safety | 1 | 2016 | 277 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2018 | 452 | 0.100 |
Why?
| Young Adult | 4 | 2019 | 10455 | 0.100 |
Why?
| Cohort Studies | 5 | 2020 | 4894 | 0.100 |
Why?
| Adult | 4 | 2021 | 30528 | 0.100 |
Why?
| Retrospective Studies | 8 | 2021 | 12542 | 0.100 |
Why?
| Professional Practice | 1 | 2011 | 62 | 0.090 |
Why?
| Child | 4 | 2021 | 18404 | 0.080 |
Why?
| Liver | 1 | 2016 | 1634 | 0.080 |
Why?
| Alprostadil | 1 | 2008 | 32 | 0.080 |
Why?
| Male | 9 | 2019 | 55555 | 0.080 |
Why?
| Risk Factors | 5 | 2020 | 8628 | 0.080 |
Why?
| Enterocolitis, Necrotizing | 1 | 2008 | 28 | 0.080 |
Why?
| Hypertension, Pulmonary | 1 | 2018 | 1728 | 0.070 |
Why?
| ROC Curve | 2 | 2019 | 442 | 0.070 |
Why?
| Vasodilator Agents | 1 | 2008 | 302 | 0.070 |
Why?
| Preoperative Care | 1 | 2008 | 319 | 0.070 |
Why?
| Pediatrics | 1 | 2011 | 979 | 0.060 |
Why?
| Prevalence | 2 | 2018 | 2249 | 0.050 |
Why?
| Limit of Detection | 1 | 2021 | 53 | 0.050 |
Why?
| Prognosis | 2 | 2019 | 3328 | 0.050 |
Why?
| Severity of Illness Index | 2 | 2019 | 2537 | 0.050 |
Why?
| Diet, Ketogenic | 1 | 2021 | 33 | 0.050 |
Why?
| Logistic Models | 2 | 2019 | 1840 | 0.050 |
Why?
| Substance Abuse Detection | 1 | 2021 | 62 | 0.050 |
Why?
| Hospitals, Urban | 1 | 2021 | 127 | 0.050 |
Why?
| Administration, Intravenous | 1 | 2021 | 124 | 0.040 |
Why?
| Canada | 1 | 2021 | 322 | 0.040 |
Why?
| Tracheostomy | 1 | 2021 | 101 | 0.040 |
Why?
| Vitamins | 1 | 2021 | 151 | 0.040 |
Why?
| Chromatography, Liquid | 1 | 2021 | 347 | 0.040 |
Why?
| Growth Charts | 1 | 2019 | 14 | 0.040 |
Why?
| Risk Assessment | 2 | 2019 | 2967 | 0.040 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2019 | 39 | 0.040 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 797 | 0.040 |
Why?
| Tandem Mass Spectrometry | 1 | 2021 | 411 | 0.040 |
Why?
| Anthropometry | 1 | 2019 | 182 | 0.040 |
Why?
| Area Under Curve | 1 | 2019 | 274 | 0.040 |
Why?
| Nutritional Status | 1 | 2021 | 287 | 0.040 |
Why?
| Intensive Care, Neonatal | 1 | 2018 | 39 | 0.040 |
Why?
| Diagnostic Techniques, Ophthalmological | 1 | 2018 | 36 | 0.040 |
Why?
| Maternal Health Services | 1 | 2019 | 79 | 0.040 |
Why?
| Respiration, Artificial | 1 | 2021 | 529 | 0.040 |
Why?
| Lipids | 1 | 2021 | 580 | 0.040 |
Why?
| North America | 1 | 2018 | 256 | 0.040 |
Why?
| Laser Coagulation | 1 | 2017 | 54 | 0.030 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2016 | 33 | 0.030 |
Why?
| Acidosis, Lactic | 1 | 2016 | 27 | 0.030 |
Why?
| Autopsy | 1 | 2016 | 84 | 0.030 |
Why?
| Urban Population | 1 | 2019 | 397 | 0.030 |
Why?
| Glucose | 1 | 2021 | 896 | 0.030 |
Why?
| Regression Analysis | 1 | 2018 | 944 | 0.030 |
Why?
| Fatal Outcome | 1 | 2016 | 284 | 0.030 |
Why?
| World Health Organization | 1 | 2016 | 102 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2018 | 1430 | 0.030 |
Why?
| Survival Rate | 1 | 2018 | 1644 | 0.030 |
Why?
| Comorbidity | 1 | 2018 | 1448 | 0.030 |
Why?
| Patient Readmission | 1 | 2018 | 609 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2017 | 1691 | 0.030 |
Why?
| Models, Theoretical | 1 | 2016 | 515 | 0.020 |
Why?
| Prostaglandins | 1 | 2011 | 77 | 0.020 |
Why?
| Internationality | 1 | 2011 | 143 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2019 | 4411 | 0.020 |
Why?
| Kidney Transplantation | 1 | 2016 | 541 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 539 | 0.020 |
Why?
| Liver Transplantation | 1 | 2016 | 707 | 0.020 |
Why?
| United States | 2 | 2017 | 12176 | 0.020 |
Why?
| Internet | 1 | 2011 | 596 | 0.020 |
Why?
| Intensive Care Units | 1 | 2008 | 617 | 0.010 |
Why?
|
|
Wymore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|